# Pymaceuticals-Analysis

![Laboratory](Images/Laboratory.jpg)

# In this study, 249 mice identified with SCC tumor growth were treated through a variety of drug regimens. Tumor development was observed and measured over the course of 45 days. The goal of the study was to compare the performance of Pymaceuticals' drug of interest, Capomulin, versus the three other treatment regimens. The executive team has asked for a top-level summary of the study results listed below.



















# Navi Sohi | Data Analytics
